NCT01780948View on ClinicalTrials.gov

Pharmacokinetic of Everolimus and Atorvastatin Co-administration

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Difference of 12-hour AUC
Interventions
DRUG

Atorvastatin 20 mg

Add atorvastatin 20 mg and compare 12-hour AUC of everolimus between Arm everolimus and everolimus with atorvastatin 20 mg

DRUG

Everolimus

Administration only everolimus, no atorvastatin. Everolimus administration with adjusted dose to target C trough (C0)level between 3-12 ng/mL.

Trial Locations (1)

10330

King Chulalongkorn Memorial Hospital, Bangkok

All Listed Sponsors
collaborator

Ratchadapiseksompotch Research Fund

UNKNOWN

lead

Chulalongkorn University

OTHER

NCT01780948 - Pharmacokinetic of Everolimus and Atorvastatin Co-administration | Biotech Hunter | Biotech Hunter